Caracterização da ativação plaquetária e interação plaquetaleucócitos na obesidade
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Obesity is a global health problem associated with chronic low-grade inflammation that
supports comorbidities such as diabetes and cardiovascular disease. However, the
thromboinflammatory mechanisms related to cardiometabolic risk are not fully known.
Platelets are effector cells of hemostasis as well as immunity and inflammation.
Activated platelets secrete inflammatory mediators and interact with leukocytes
modulating responses such as secretion, migration, antibody class switching and T cell
polarization. Nonetheless, the mechanisms and functional responses of platelets and
platelet-leukocyte aggregates in obesity remain poorly understood. Our hypothesis is
that platelet activation contributes to immunoregulation in obesity, participating in
mechanisms of inflammation and high cardiometabolic risk. The main goal of the
present project is to investigate the role of platelet activation and platelet-leukocyte
interaction in immunoregulation and inflammation in obesity. Blood samples were
obtained from obese and eutrophic individuals and analyzed to thromboinflammatory
mediators in plasma and platelet activation by flow cytometry. Individuals with obesity
have increased levels of thromboinflammation markers and platelet activation with
greater secretion of dense granules. Platelets from patients with grade III to IV obesity
have higher activation and hyper-responsive to thrombin. Leukocyte subpopulations
and circulating platelet-leukocyte aggregates were characterized in whole blood
samples by flow cytometry. We demonstrated that obesity induces the formation of
platelet-monocyte aggregates, but not platelets with and T, B, NK and NKT
lymphocytes and neutrophils interaction. Circulating platelet-monocyte aggregates in
obese individuals is associated with CD16+ monocyte subpopulations and increased
expression of TF (tissue factor), the main activator of the extrinsic cascade of
coagulation. Furthermore, we investigated the role of leptin, a classic inflammatory
mediator increased in obesity, in the formation of platelet-leukocyte aggregates and
TF expression in monocytes. Leptin partially reproduces the phenotype observed in
obese individuals, inducing TF expression in monocytes associated with platelet
interaction. To investigate the role of platelet-monocyte interaction in the reciprocal
activation of platelets and monocytes in obesity, we initially used an autologous
platelet-monocyte interaction model from obese or eutrophic individuals and measured
mediators secreted by ELISA. Platelets and monocytes from obese patients are more
activated with secretion of inflammatory mediators TNF-α, IL-10, sCD62P e
CCL5/RANTES. Considering that higher activation of platelets and monocytes from
patients with obesity, we investigated whether the platelet-monocyte interaction
contributes to reciprocal activation of platelets and monocytes in obesity, using an ex
vivo heterologous co-culture model. The platelet-monocyte interaction induced TF
expression in monocytes, as well as potentiating the reciprocal activation of platelets
and monocytes, amplifying the secretion of thromboinflammatory mediators such as
CCL2/MCP-1, IL-1β and sCD62P. Together, the data highlight the participation of both
cells in the reprogramming of their responses during platelet-monocyte interaction in
obesity. All these cell interaction events are potentially involved in
thromboinflammation mechanisms in obesity.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

